South San Francisco, CA Breaking News Headlines Today

News about South San Francisco

Stay current with all the latest and breaking news about South San Francisco, compare headlines and perspectives between news sources on stories happening today. In total, 64 stories have been published about South San Francisco which Ground News has aggregated in the past 3 months.

Local News Publishers

Untracked bias

Suggest a source

Looking for a source we don't already have? Suggest one here.

Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - Tenaya Therapeutics (NASDAQ:TNYA)

100% Center coverage: 1 sources

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya's Chief Executive Officer, will participate in the following October investor and industry conferences. Details are below: Cell & Gene …South San Francisco · South San Francisco Read Article

Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 2, 2025-South San Francisco · South San Francisco Read Article

Corvus Pharmaceuticals Appoints David Moore to Board of Directors - Corvus Pharma (NASDAQ:CRVS)

100% Center coverage: 1 sources

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US Operations at Novo Nordisk A/S and President at Novo Nordisk Inc., has been appointed to the company's Board of Directors. Mr. Moore brings a wealth of experience from his 27-year career in the industry, including broad expertise acros…Novo Nordisk · South San Francisco Read Article

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order

80% Center coverage: 10 sources

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 30, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously announced Business Combination Agreement with XenoTherapeutics Inc. ("Xeno"), a non-profit biotechnology…South San Francisco · South San Francisco See the Story

Star Therapeutics Gains $125m Series D Funds to Develop Pipeline

Star Therapeutics has completed a Series D funding round, raising $125m, aimed at supporting its pipeline progression.Startups · South San Francisco See the Story

Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK)

100% Center coverage: 1 sources

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the recipient of unusually large options trading activity on Monday. Investors purchased 21,076 call options on the company. This is an increase of 1,008% compared to the typical volume of 1,902 call options. Analysts Set New Price Targets CYTK has been the subject of several recent analyst reports. Raymond James Financial initiated coverage on Cytokinetics in a research note on Wedn…South San Francisco · South San Francisco Read Article

Cytokinetics, Incorporated (CYTK): Biotech Stock With 48% Upside Potential And Robust Revenue Growth

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a market capitalization of $6.03 billion and a formidable presence in muscle biology drug development. This late-stage biopharmaceutical company, headquartered in South San Francisco, is at the forefront of developing small molecule drug candidates aimed at treating debilitating diseases by enhancing muscle function and contractility. Notably, the company’…South San Francisco · South San Francisco Read Article

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of ...

100% Left coverage: 1 sources

SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that the…South San Francisco · South San Francisco Read Article

San Mateo unveils $597M wastewater plant, largest infrastructure project in city history - Local News Matters

AFTER MORE THAN FIVE YEARS of construction, San Mateo’s upgraded Wastewater Treatment Plant was unveiled in a ribbon-cutting ceremony. It is the largest infrastructure project in San Mateo’s history, and developers say it’s one of the most sustainable wastewater treatment facilities in the country. Dozens of local leaders, such as U.S. Rep. Kevin Mullin, D-South San Francisco, San Mateo County Supervisor Noelia Corzo, Foster City Mayor Stacy Ji…South San Francisco · South San Francisco Read Article

Why CytomX Therapeutics Stock Was Skyrocketing This Week @themotleyfool #stocks $CTMX

100% Left coverage: 1 sources

Key PointsAn analyst initiated coverage on the biotech, and how.She feels it could more than double in price from current levels.10 stocks we like better than CytomX Therapeutics › It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics (NASDAQ: CTMX). An analyst initiated coverage of the cancer-focused dr…Stock Markets · South San Francisco Read Article